Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M80,167Revenue $M23,113Net Margin (%)13.3Z-Score4.6
Enterprise Value $M80,976EPS $4.3Operating Margin %15.7F-Score4
P/E(ttm))28.8Cash Flow Per Share $5.4Pre-tax Margin (%)16.7Higher ROA y-yN
Price/Book4.510-y EBITDA Growth Rate %12.7Quick Ratio1.2Cash flow > EarningsY
Price/Sales3.85-y EBITDA Growth Rate %0.4Current Ratio1.6Lower Leverage y-yN
Price/Cash Flow9.1y-y EBITDA Growth Rate %-34.0ROA % (ttm)7.7Higher Current Ratio y-yN
Dividend Yield %2.7Insider Buy (3m)0ROE % (ttm)15.2Less Shares Outstanding y-yY
Payout Ratio %78.0Shares Outstanding M1,113ROI % (ttm)23.7Gross Margin Increase y-yN

Gurus Latest Trades with LLY

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
LLYKen Fisher 2014-12-31 Add0.07%$61.9 - $72.83
($67.53)
$ 727%Add 383.26%578,992
LLYJohn Hussman 2014-09-30 Add1.67%$60.35 - $66.59
($63.3)
$ 7214%Add 6000%305,000
LLYKen Fisher 2014-09-30 Add0.02%$60.35 - $66.59
($63.3)
$ 7214%Add 2742.47%119,810
LLYJoel Greenblatt 2014-09-30 Reduce$60.35 - $66.59
($63.3)
$ 7214%Reduce -27.37%5,628
LLYDodge & Cox 2014-09-30 Add$60.35 - $66.59
($63.3)
$ 7214%Add 20.38%42,464
LLYCharles Brandes 2014-09-30 Reduce-0.29%$60.35 - $66.59
($63.3)
$ 7214%Reduce -14.27%2,303,062
LLYHOTCHKIS & WILEY 2014-09-30 Reduce-0.12%$60.35 - $66.59
($63.3)
$ 7214%Reduce -10.92%4,321,666
LLYDavid Dreman 2014-09-30 Reduce-0.02%$60.35 - $66.59
($63.3)
$ 7214%Reduce -84.4%900
LLYGeorge Soros 2014-09-30 Sold Out -0.02%$60.35 - $66.59
($63.3)
$ 7214%Sold Out0
LLYHOTCHKIS & WILEY 2014-06-30 Add0.73%$58.21 - $63.1
($59.62)
$ 7221%Add 199.7%4,851,480
LLYGeorge Soros 2014-06-30 Buy 0.02%$58.21 - $63.1
($59.62)
$ 7221%New holding, 50441 sh.50,441
LLYVanguard Health Care Fund 2014-06-30 Reduce-0.15%$58.21 - $63.1
($59.62)
$ 7221%Reduce -3.98%21,982,700
LLYJohn Hussman 2014-06-30 Reduce-0.02%$58.21 - $63.1
($59.62)
$ 7221%Reduce -50%5,000
LLYRay Dalio 2014-06-30 Sold Out -0.02%$58.21 - $63.1
($59.62)
$ 7221%Sold Out0
LLYPRIMECAP Management 2014-03-31 Add0.37%$50.73 - $59.85
($55.61)
$ 7230%Add 10.83%57,129,708
LLYHOTCHKIS & WILEY 2014-03-31 Buy 0.35%$50.73 - $59.85
($55.61)
$ 7230%New holding, 1618802 sh.1,618,802
LLYJoel Greenblatt 2014-03-31 Reduce-0.16%$50.73 - $59.85
($55.61)
$ 7230%Reduce -93.61%9,016
LLYRay Dalio 2014-03-31 Reduce-0.01%$50.73 - $59.85
($55.61)
$ 7230%Reduce -34.83%31,439
LLYVanguard Health Care Fund 2013-12-31 Add0.67%$47.65 - $51.34
($50.05)
$ 7244%Add 22.98%22,895,000
LLYCharles Brandes 2013-12-31 Add0.19%$47.65 - $51.34
($50.05)
$ 7244%Add 12.57%2,711,949
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

LLY is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
LLY Ken Fisher 2014-12-31578,9920.050.08+383.26%
LLY John Hussman 2014-09-30305,0000.031.7+6000%
LLY Ken Fisher 2014-09-30119,8100.010.02+2742.47%
LLY Dodge & Cox 2014-09-3042,46400+20.38%
LLY PRIMECAP Management 2014-09-3057,100,5455.134
LLY Vanguard Health Care Fund 2014-09-3021,982,7001.973.6
LLY Richard Pzena 2014-09-30430,1750.040.15-0.27%
LLY Mario Gabelli 2014-09-30114,6000.010.04-4.5%
LLY HOTCHKIS & WILEY 2014-09-304,321,6660.391-10.92%
LLY Charles Brandes 2014-09-302,303,0620.212-14.27%
LLY Joel Greenblatt 2014-09-305,62800-27.37%
LLY David Dreman 2014-09-3090000-84.4%
LLY George Soros 2014-09-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


LLY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LILLY ENDOWMENT INC10% Owner 2014-12-04Sell190,000$71.920.26view
LILLY ENDOWMENT INC10% Owner 2014-12-02Sell180,000$70.142.81view
LILLY ENDOWMENT INC10% Owner 2014-11-13Sell200,000$67.736.47view
LILLY ELI & CO 2014-11-12Buy164,963$13.5434.15view
Zakrowski Donald AChief Accounting Officer 2014-11-11Sell750$68.495.29view
LILLY ENDOWMENT INC10% Owner 2014-11-05Sell180,000$677.63view
Walsh Fionnuala MSVP, Global Quality 2014-11-04Sell15,000$677.63view
Conterno Enrique ASr. VP & Pres., Lilly Diabetes 2014-11-03Sell5,000$66.039.21view
Walsh Fionnuala MSVP, Global Quality 2014-10-31Sell7,376$66.588.31view
LILLY ENDOWMENT INC10% Owner 2014-10-31Sell190,000$66.48.6view

Press Releases about LLY :

    Quarterly/Annual Reports about LLY:

    News about LLY:

    Articles On GuruFocus.com
    Feeling Good With This Med Company Jan 20 2015 
    Sarah Ketterer Dives in when Others Pull Out Nov 14 2014 
    Weekly 52-Week Highs Highlight: LLY, BG, NVS, HRL Sep 07 2014 
    Higher Yielding Stocks With A Cheap EV/EBITDA Ratio And Low Debt Figures Aug 28 2014 
    Eli Lilly is on the Right Track Jun 25 2014 
    John Paulson's Stocks Trading for Less Than He Paid for Them Jun 02 2014 
    Johnson & Johnson (JNJ) Dividend Stock Analysis May 29 2014 
    Can Pfizer Make Up Its Loss? May 09 2014 
    Will Pfizer’s Q1 2014 Earnings Beat the Street on May 5, 2014? May 05 2014 
    Vanguard Health Care Fund's Top Quarterly Holdings Apr 30 2014 


    More From Other Websites
    Will Generics Continue to Hit Eli Lilly's (LLY) Q4 Earnings? - Analyst Blog Jan 29 2015
    What to Expect When Eli Lilly (LLY) Reports Fourth-Quarter Earnings Tomorrow Jan 29 2015
    Scoring Progress Against Cancer: New Tool Measures Cancer Progress to Help Inform Research and... Jan 29 2015
    Novartis (NVS) Up on Earnings and Revenue Beat in Q4 - Analyst Blog Jan 28 2015
    Markets Hitting Highs: Unseen Contaminants to Rationality Jan 28 2015
    Up to Speed: Peltz receives ammo in fight against DuPont (Video) Jan 28 2015
    Will Anthem (ANTM) Be Able to Beat Q4 Earnings Estimates? - Analyst Blog Jan 27 2015
    CytRx Candidate Encourages in Soft Tissue Sarcoma Study - Analyst Blog Jan 26 2015
    Box's fierce rivals Jan 22 2015
    CytRx Relieved as FDA Lifts Partial Hold on Oncology Drug - Analyst Blog Jan 21 2015
    Bristol-Myers Names New CEO Jan 20 2015
    Will Pharmaceutical Segment Drive J&J Q4 Earnings Again? - Analyst Blog Jan 19 2015
    A Pair Trade With Eli Lilly And Johnson & Johnson? Goldman Just Explained Why It's A Solid Idea Jan 15 2015
    Eli Lilly Has 'Turned The Corner,' Upgraded Jan 15 2015
    Healthcare Executives on a Saturday Jan 15 2015
    Eli Lilly (LLY) Stock Upgraded Today at Goldman Sachs Jan 15 2015
    Eli Lilly Inks Oncology Deals with Merck, Bristol-Myers - Analyst Blog Jan 14 2015
    AstraZeneca Drug Improves Outcomes After Heart Attacks Jan 14 2015
    Eli Lilly CEO Sees `Big Amount' of Industry M&A in 2015 Jan 13 2015
    FDA Bans Cialis From a Plant Where Lilly Says Drugs Aren't Made Jan 13 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK